historical and laboratory evidence indicated that the substance was pyridostigmine bromide , a low-molecular-weight drug with which the patient had been treated after her disease was misdiagnosed as myasthenia gravis .
C0034262
pyridostigmine bromide
C0026896
myasthenia gravis